ID   IL2RA_HUMAN             Reviewed;         272 AA.
AC   P01589; Q5W007;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   21-JUL-1986, sequence version 1.
DT   28-JAN-2026, entry version 235.
DE   RecName: Full=Interleukin-2 receptor subunit alpha;
DE            Short=IL-2 receptor subunit alpha;
DE            Short=IL-2-RA;
DE            Short=IL-2R subunit alpha;
DE            Short=IL2-RA;
DE   AltName: Full=TAC antigen;
DE   AltName: Full=p55;
DE   AltName: CD_antigen=CD25;
DE   Flags: Precursor;
GN   Name=IL2RA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=6090949; DOI=10.1038/311631a0;
RA   Nikaido T., Shimizu A., Ishida N., Sabe H., Teshigawara K., Maeda M.,
RA   Uchiyama T., Yodoi J., Honjo T.;
RT   "Molecular cloning of cDNA encoding human interleukin-2 receptor.";
RL   Nature 311:631-635(1984).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=6090948; DOI=10.1038/311626a0;
RA   Leonard W.J., Depper J.M., Crabtree G.R., Rudikoff S., Pumphrey J.,
RA   Robb R.J., Kroenke M., Svetlik P.B., Peffer N.J., Waldmann T.A.,
RA   Greene W.C.;
RT   "Molecular cloning and expression of cDNAs for the human interleukin-2
RT   receptor.";
RL   Nature 311:626-631(1984).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2999698; DOI=10.1093/nar/13.21.7579;
RA   Ishida N., Kanamori H., Noma T., Nikaido T., Sabe H., Suzuki N.,
RA   Shimizu A., Honjo T.;
RT   "Molecular cloning and structure of the human interleukin 2 receptor
RT   gene.";
RL   Nucleic Acids Res. 13:7579-7589(1985).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2996141; DOI=10.1126/science.2996141;
RA   Leonard W.J., Depper J.M., Kanehisa M., Kroenke M., Peffer N.J.,
RA   Svetlik P.B., Sullivan M., Greene W.C.;
RT   "Structure of the human interleukin-2 receptor gene.";
RL   Science 230:633-639(1985).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT THR-272.
RG   SeattleSNPs variation discovery resource;
RL   Submitted (MAR-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Cahill P., Camire D., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S., Corby N.,
RA   Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L., Frankish A.,
RA   Frankland J.A., Garner P., Garnett J., Gribble S., Griffiths C.,
RA   Grocock R., Gustafson E., Hammond S., Harley J.L., Hart E., Heath P.D.,
RA   Ho T.P., Hopkins B., Horne J., Howden P.J., Huckle E., Hynds C.,
RA   Johnson C., Johnson D., Kana A., Kay M., Kimberley A.M., Kershaw J.K.,
RA   Kokkinaki M., Laird G.K., Lawlor S., Lee H.M., Leongamornlert D.A.,
RA   Laird G., Lloyd C., Lloyd D.M., Loveland J., Lovell J., McLaren S.,
RA   McLay K.E., McMurray A., Mashreghi-Mohammadi M., Matthews L., Milne S.,
RA   Nickerson T., Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V.,
RA   Peck A.I., Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A.,
RA   Ross M.T., Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W., Tracey A.,
RA   Tromans A., Tsolas J., Wall M., Walsh J., Wang H., Weinstock K., West A.P.,
RA   Willey D.L., Whitehead S.L., Wilming L., Wray P.W., Young L., Chen Y.,
RA   Lovering R.C., Moschonas N.K., Siebert R., Fechtel K., Bentley D.,
RA   Durbin R.M., Hubbard T., Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-21.
RX   PubMed=3030566; DOI=10.1016/0092-8674(87)90754-9;
RA   Cross S.L., Feinberg M.B., Wolf J.B., Holbrook N.J., Wong-Stall F.,
RA   Leonard W.J.;
RT   "Regulation of the human interleukin-2 receptor alpha chain promoter:
RT   activation of a nonfunctional promoter by the transactivator gene of HTLV-
RT   I.";
RL   Cell 49:47-56(1987).
RN   [9]
RP   DISULFIDE BONDS, AND GLYCOSYLATION AT ASN-70; ASN-89; THR-218; THR-224;
RP   THR-229 AND THR-237.
RX   PubMed=3134887; DOI=10.1016/0006-291x(88)90695-x;
RA   Miedel M.C., Hulmes J.D., Weber D.V., Bailon P., Pan Y.C.;
RT   "Structural analysis of recombinant soluble human interleukin-2 receptor.
RT   Primary structure, assignment of disulfide bonds and core IL-2 binding
RT   structure.";
RL   Biochem. Biophys. Res. Commun. 154:372-379(1988).
RN   [10]
RP   3D-STRUCTURE MODELING OF 23-83.
RX   PubMed=7529123; DOI=10.1016/s0969-2126(94)00085-9;
RA   Bamborough P., Hedgecock C.J., Richards W.G.;
RT   "The interleukin-2 and interleukin-4 receptors studied by molecular
RT   modelling.";
RL   Structure 2:839-851(1994).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 22-238 IN COMPLEX WITH IL2; IL2RB
RP   AND IL2RC, AND DISULFIDE BONDS.
RX   PubMed=16293754; DOI=10.1126/science.1117893;
RA   Wang X., Rickert M., Garcia K.C.;
RT   "Structure of the quaternary complex of interleukin-2 with its alpha, beta,
RT   and gammac receptors.";
RL   Science 310:1159-1163(2005).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS) OF 22-233 IN COMPLEX WITH IL2; IL2RB
RP   AND IL2RC, AND DISULFIDE BONDS.
RX   PubMed=16477002; DOI=10.1073/pnas.0511161103;
RA   Stauber D.J., Debler E.W., Horton P.A., Smith K.A., Wilson I.A.;
RT   "Crystal structure of the IL-2 signaling complex: paradigm for a
RT   heterotrimeric cytokine receptor.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:2788-2793(2006).
RN   [13]
RP   INVOLVEMENT IN T1D10.
RX   PubMed=17676041; DOI=10.1038/ng2102;
RA   Lowe C.E., Cooper J.D., Brusko T., Walker N.M., Smyth D.J., Bailey R.,
RA   Bourget K., Plagnol V., Field S., Atkinson M., Clayton D.G., Wicker L.S.,
RA   Todd J.A.;
RT   "Large-scale genetic fine mapping and genotype-phenotype associations
RT   implicate polymorphism in the IL2RA region in type 1 diabetes.";
RL   Nat. Genet. 39:1074-1082(2007).
RN   [14]
RP   FUNCTION, INVOLVEMENT IN IMD41, VARIANT IMD41 ASN-166, AND CHARACTERIZATION
RP   OF VARIANT IMD41 ASN-166.
RX   PubMed=23416241; DOI=10.1016/j.clim.2013.01.004;
RA   Goudy K., Aydin D., Barzaghi F., Gambineri E., Vignoli M.,
RA   Ciullini Mannurita S., Doglioni C., Ponzoni M., Cicalese M.P.,
RA   Assanelli A., Tommasini A., Brigida I., Dellepiane R.M., Martino S.,
RA   Olek S., Aiuti A., Ciceri F., Roncarolo M.G., Bacchetta R.;
RT   "Human IL2RA null mutation mediates immunodeficiency with
RT   lymphoproliferation and autoimmunity.";
RL   Clin. Immunol. 146:248-261(2013).
RN   [15]
RP   FUNCTION, INVOLVEMENT IN IMD41, AND VARIANT IMD41 SER-41.
RX   PubMed=24116927; DOI=10.1111/cei.12214;
RA   Bezrodnik L., Caldirola M.S., Seminario A.G., Moreira I., Gaillard M.I.;
RT   "Follicular bronchiolitis as phenotype associated with CD25 deficiency.";
RL   Clin. Exp. Immunol. 175:227-234(2014).
CC   -!- FUNCTION: Receptor for interleukin-2. The receptor is involved in the
CC       regulation of immune tolerance by controlling regulatory T cells
CC       (TREGs) activity. TREGs suppress the activation and expansion of
CC       autoreactive T-cells. {ECO:0000269|PubMed:23416241,
CC       ECO:0000269|PubMed:24116927}.
CC   -!- SUBUNIT: Non-covalent dimer of an alpha and a beta subunit. IL2R exists
CC       in 3 different forms: a high affinity dimer, an intermediate affinity
CC       monomer (beta subunit), and a low affinity monomer (alpha subunit). The
CC       high and intermediate affinity forms also associate with a gamma
CC       subunit. {ECO:0000269|PubMed:16293754, ECO:0000269|PubMed:16477002}.
CC   -!- INTERACTION:
CC       P01589; P60568: IL2; NbExp=3; IntAct=EBI-8614302, EBI-12508717;
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane protein.
CC   -!- DISEASE: Type 1 diabetes mellitus 10 (T1D10) [MIM:601942]: A
CC       multifactorial disorder of glucose homeostasis that is characterized by
CC       susceptibility to ketoacidosis in the absence of insulin therapy.
CC       Clinical features are polydipsia, polyphagia and polyuria which result
CC       from hyperglycemia-induced osmotic diuresis and secondary thirst. These
CC       derangements result in long-term complications that affect the eyes,
CC       kidneys, nerves, and blood vessels. {ECO:0000269|PubMed:17676041}.
CC       Note=Disease susceptibility is associated with variants affecting the
CC       gene represented in this entry.
CC   -!- DISEASE: Immunodeficiency 41 with lymphoproliferation and autoimmunity
CC       (IMD41) [MIM:606367]: A disorder of immune dysregulation characterized
CC       by recurrent viral, fungal, and bacterial infections, lymphadenopathy,
CC       and variable autoimmune features, such as autoimmune enteropathy and
CC       eczematous skin lesions. {ECO:0000269|PubMed:23416241,
CC       ECO:0000269|PubMed:24116927}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- WEB RESOURCE: Name=IL2RAbase; Note=IL2RA mutation db;
CC       URL="https://databases.lovd.nl/shared/genes/IL2RA";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X01057; CAA25525.1; -; mRNA.
DR   EMBL; X03131; CAA26906.1; -; Genomic_DNA.
DR   EMBL; X03132; CAA26906.1; JOINED; Genomic_DNA.
DR   EMBL; X03133; CAA26906.1; JOINED; Genomic_DNA.
DR   EMBL; X03134; CAA26906.1; JOINED; Genomic_DNA.
DR   EMBL; X03135; CAA26906.1; JOINED; Genomic_DNA.
DR   EMBL; X03136; CAA26906.1; JOINED; Genomic_DNA.
DR   EMBL; X03137; CAA26906.1; JOINED; Genomic_DNA.
DR   EMBL; X03138; CAA26906.1; JOINED; Genomic_DNA.
DR   EMBL; K03122; AAB59535.1; ALT_SEQ; mRNA.
DR   EMBL; M11066; AAA67527.1; -; Genomic_DNA.
DR   EMBL; M10322; AAA67527.1; JOINED; Genomic_DNA.
DR   EMBL; M11060; AAA67527.1; JOINED; Genomic_DNA.
DR   EMBL; M11061; AAA67527.1; JOINED; Genomic_DNA.
DR   EMBL; M11062; AAA67527.1; JOINED; Genomic_DNA.
DR   EMBL; M11063; AAA67527.1; JOINED; Genomic_DNA.
DR   EMBL; M11064; AAA67527.1; JOINED; Genomic_DNA.
DR   EMBL; M11065; AAA67527.1; JOINED; Genomic_DNA.
DR   EMBL; AY563103; AAS55572.1; -; Genomic_DNA.
DR   EMBL; AL157395; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL137186; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471072; EAW86414.1; -; Genomic_DNA.
DR   EMBL; M15864; AAA59162.1; -; Genomic_DNA.
DR   EMBL; BN000945; CAK26553.1; -; Genomic_DNA.
DR   CCDS; CCDS7076.1; -.
DR   PIR; A44186; UHHU2.
DR   RefSeq; NP_000408.1; NM_000417.3.
DR   RefSeq; NP_001295171.1; NM_001308242.1.
DR   RefSeq; NP_001295172.1; NM_001308243.1.
DR   PDB; 1Z92; X-ray; 2.80 A; B=22-238.
DR   PDB; 2B5I; X-ray; 2.30 A; D=22-238.
DR   PDB; 2ERJ; X-ray; 3.00 A; A/E=22-233.
DR   PDB; 3IU3; X-ray; 2.90 A; I/J/K=22-238.
DR   PDB; 3NFP; X-ray; 2.86 A; I/K=22-238.
DR   PDB; 6VWU; X-ray; 3.40 A; A=22-186.
DR   PDB; 6YIO; X-ray; 1.83 A; B=22-213.
DR   PDB; 7F9W; EM; 3.20 A; A=26-186.
DR   PDB; 7ZMZ; X-ray; 3.20 A; D=21-238.
DR   PDBsum; 1Z92; -.
DR   PDBsum; 2B5I; -.
DR   PDBsum; 2ERJ; -.
DR   PDBsum; 3IU3; -.
DR   PDBsum; 3NFP; -.
DR   PDBsum; 6VWU; -.
DR   PDBsum; 6YIO; -.
DR   PDBsum; 7F9W; -.
DR   PDBsum; 7ZMZ; -.
DR   AlphaFoldDB; P01589; -.
DR   EMDB; EMD-31499; -.
DR   SMR; P01589; -.
DR   BioGRID; 109774; 84.
DR   ComplexPortal; CPX-646; Interleukin-2 receptor-ligand complex.
DR   CORUM; P01589; -.
DR   DIP; DIP-1080N; -.
DR   FunCoup; P01589; 1086.
DR   IntAct; P01589; 45.
DR   MINT; P01589; -.
DR   STRING; 9606.ENSP00000369293; -.
DR   BindingDB; P01589; -.
DR   ChEMBL; CHEMBL1778; -.
DR   DrugBank; DB00041; Aldesleukin.
DR   DrugBank; DB00074; Basiliximab.
DR   DrugBank; DB16411; Camidanlumab tesirine.
DR   DrugBank; DB00111; Daclizumab.
DR   DrugBank; DB00004; Denileukin diftitox.
DR   DrugBank; DB15628; Inolimomab.
DR   DrugCentral; P01589; -.
DR   GuidetoPHARMACOLOGY; 1695; -.
DR   GlyCosmos; P01589; 6 sites, No reported glycans.
DR   GlyGen; P01589; 8 sites, 2 N-linked glycans (1 site), 1 O-linked glycan (2 sites).
DR   iPTMnet; P01589; -.
DR   PhosphoSitePlus; P01589; -.
DR   BioMuta; IL2RA; -.
DR   DMDM; 124317; -.
DR   MassIVE; P01589; -.
DR   PaxDb; 9606-ENSP00000369293; -.
DR   PeptideAtlas; P01589; -.
DR   ProteomicsDB; 51393; -.
DR   ABCD; P01589; 14 sequenced antibodies.
DR   Antibodypedia; 3715; 3397 antibodies from 57 providers.
DR   DNASU; 3559; -.
DR   Ensembl; ENST00000379959.8; ENSP00000369293.3; ENSG00000134460.19.
DR   GeneID; 3559; -.
DR   KEGG; hsa:3559; -.
DR   MANE-Select; ENST00000379959.8; ENSP00000369293.3; NM_000417.3; NP_000408.1.
DR   UCSC; uc001iiz.3; human.
DR   AGR; HGNC:6008; -.
DR   ClinPGx; PA29828; -.
DR   CTD; 3559; -.
DR   DisGeNET; 3559; -.
DR   GeneCards; IL2RA; -.
DR   HGNC; HGNC:6008; IL2RA.
DR   HPA; ENSG00000134460; Tissue enhanced (adipose tissue, lymphoid tissue, urinary bladder).
DR   MalaCards; IL2RA; -.
DR   MIM; 147730; gene.
DR   MIM; 601942; phenotype.
DR   MIM; 606367; phenotype.
DR   OpenTargets; ENSG00000134460; -.
DR   Orphanet; 169100; Immunodeficiency due to CD25 deficiency.
DR   Orphanet; 85410; Oligoarticular juvenile idiopathic arthritis.
DR   Orphanet; 85408; Rheumatoid factor-negative polyarticular juvenile idiopathic arthritis.
DR   VEuPathDB; HostDB:ENSG00000134460; -.
DR   eggNOG; ENOG502SUAG; Eukaryota.
DR   GeneTree; ENSGT00390000018872; -.
DR   InParanoid; P01589; -.
DR   OMA; TILNCEC; -.
DR   OrthoDB; 9833060at2759; -.
DR   PAN-GO; P01589; 2 GO annotations based on evolutionary models.
DR   PhylomeDB; P01589; -.
DR   PathwayCommons; P01589; -.
DR   Reactome; R-HSA-5673001; RAF/MAP kinase cascade.
DR   Reactome; R-HSA-8877330; RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs).
DR   Reactome; R-HSA-9020558; Interleukin-2 signaling.
DR   Reactome; R-HSA-912526; Interleukin receptor SHC signaling.
DR   SignaLink; P01589; -.
DR   SIGNOR; P01589; -.
DR   Agora; ENSG00000134460; -.
DR   BioGRID-ORCS; 3559; 22 hits in 1155 CRISPR screens.
DR   ChiTaRS; IL2RA; human.
DR   EvolutionaryTrace; P01589; -.
DR   GeneWiki; IL2RA; -.
DR   GenomeRNAi; 3559; -.
DR   Pharos; P01589; Tclin.
DR   PRO; PR:P01589; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   RNAct; P01589; protein.
DR   Bgee; ENSG00000134460; Expressed in lymph node and 112 other cell types or tissues.
DR   ExpressionAtlas; P01589; baseline and differential.
DR   GO; GO:0009897; C:external side of plasma membrane; IEA:Ensembl.
DR   GO; GO:0005893; C:interleukin-2 receptor complex; TAS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0019976; F:interleukin-2 binding; IBA:GO_Central.
DR   GO; GO:0004911; F:interleukin-2 receptor activity; IDA:UniProt.
DR   GO; GO:0050798; P:activated T cell proliferation; IEA:Ensembl.
DR   GO; GO:0006924; P:activation-induced cell death of T cells; IEA:Ensembl.
DR   GO; GO:0006915; P:apoptotic process; TAS:ProtInc.
DR   GO; GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc.
DR   GO; GO:0006955; P:immune response; TAS:ProtInc.
DR   GO; GO:0006954; P:inflammatory response; IBA:GO_Central.
DR   GO; GO:0002437; P:inflammatory response to antigenic stimulus; IEA:Ensembl.
DR   GO; GO:0038110; P:interleukin-2-mediated signaling pathway; IDA:UniProt.
DR   GO; GO:0050728; P:negative regulation of inflammatory response; IEA:Ensembl.
DR   GO; GO:0042130; P:negative regulation of T cell proliferation; IEA:Ensembl.
DR   GO; GO:0007219; P:Notch signaling pathway; IEA:Ensembl.
DR   GO; GO:0042104; P:positive regulation of activated T cell proliferation; IEA:Ensembl.
DR   GO; GO:0045582; P:positive regulation of T cell differentiation; IEA:Ensembl.
DR   GO; GO:2000561; P:regulation of CD4-positive, alpha-beta T cell proliferation; IEA:Ensembl.
DR   GO; GO:0046013; P:regulation of T cell homeostatic proliferation; IEA:Ensembl.
DR   GO; GO:0002664; P:regulation of T cell tolerance induction; IMP:UniProtKB.
DR   CDD; cd00033; CCP; 1.
DR   FunFam; 2.10.70.10:FF:000156; Interleukin-2 receptor subunit alpha; 1.
DR   FunFam; 2.20.28.230:FF:000002; Interleukin-2 receptor subunit alpha; 1.
DR   FunFam; 2.20.28.230:FF:000003; Interleukin-2 receptor subunit alpha; 1.
DR   FunFam; 2.20.28.230:FF:000004; Interleukin-2 receptor subunit alpha; 1.
DR   Gene3D; 2.20.28.230; -; 3.
DR   InterPro; IPR015486; IL-2_rcpt_alpha.
DR   InterPro; IPR035976; Sushi/SCR/CCP_sf.
DR   InterPro; IPR000436; Sushi_SCR_CCP_dom.
DR   PANTHER; PTHR10573; INTERLEUKIN-2 RECEPTOR ALPHA CHAIN; 1.
DR   PANTHER; PTHR10573:SF0; INTERLEUKIN-2 RECEPTOR SUBUNIT ALPHA; 1.
DR   Pfam; PF00084; Sushi; 1.
DR   SMART; SM00032; CCP; 2.
DR   SUPFAM; SSF57535; Complement control module/SCR domain; 2.
DR   PROSITE; PS50923; SUSHI; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Diabetes mellitus; Disease variant; Disulfide bond;
KW   Glycoprotein; Immunity; Membrane; Proteomics identification; Receptor;
KW   Reference proteome; Repeat; Signal; Sushi; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL          1..21
FT   CHAIN           22..272
FT                   /note="Interleukin-2 receptor subunit alpha"
FT                   /id="PRO_0000011024"
FT   TOPO_DOM        22..240
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        241..259
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        260..272
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          22..84
FT                   /note="Sushi 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00302"
FT   DOMAIN          123..186
FT                   /note="Sushi 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00302"
FT   REGION          87..123
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          190..212
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        87..98
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        195..209
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   CARBOHYD        70
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:3134887"
FT   CARBOHYD        89
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:3134887"
FT   CARBOHYD        218
FT                   /note="O-linked (GalNAc...) threonine"
FT                   /evidence="ECO:0000269|PubMed:3134887"
FT   CARBOHYD        224
FT                   /note="O-linked (GalNAc...) threonine"
FT                   /evidence="ECO:0000269|PubMed:3134887"
FT   CARBOHYD        229
FT                   /note="O-linked (GalNAc...) threonine"
FT                   /evidence="ECO:0000269|PubMed:3134887"
FT   CARBOHYD        237
FT                   /note="O-linked (GalNAc...) threonine"
FT                   /evidence="ECO:0000269|PubMed:3134887"
FT   DISULFID        24..168
FT   DISULFID        49..80
FT   DISULFID        51..82
FT   DISULFID        67..125
FT   DISULFID        152..184
FT   VARIANT         41
FT                   /note="Y -> S (in IMD41; dbSNP:rs796051888)"
FT                   /evidence="ECO:0000269|PubMed:24116927"
FT                   /id="VAR_074641"
FT   VARIANT         166
FT                   /note="S -> N (in IMD41; the receptor does not localize to
FT                   the plasma membrane; dbSNP:rs796051887)"
FT                   /evidence="ECO:0000269|PubMed:23416241"
FT                   /id="VAR_074642"
FT   VARIANT         272
FT                   /note="I -> T (in dbSNP:rs12722712)"
FT                   /evidence="ECO:0000269|Ref.5"
FT                   /id="VAR_019280"
FT   STRAND          34..37
FT                   /evidence="ECO:0007829|PDB:6YIO"
FT   STRAND          39..42
FT                   /evidence="ECO:0007829|PDB:6YIO"
FT   STRAND          46..48
FT                   /evidence="ECO:0007829|PDB:6YIO"
FT   STRAND          55..57
FT                   /evidence="ECO:0007829|PDB:2B5I"
FT   STRAND          63..69
FT                   /evidence="ECO:0007829|PDB:6YIO"
FT   STRAND          74..78
FT                   /evidence="ECO:0007829|PDB:6YIO"
FT   STRAND          82..84
FT                   /evidence="ECO:0007829|PDB:2B5I"
FT   STRAND          135..137
FT                   /evidence="ECO:0007829|PDB:3IU3"
FT   STRAND          143..145
FT                   /evidence="ECO:0007829|PDB:3NFP"
FT   STRAND          147..152
FT                   /evidence="ECO:0007829|PDB:6YIO"
FT   STRAND          157..162
FT                   /evidence="ECO:0007829|PDB:2B5I"
FT   STRAND          165..171
FT                   /evidence="ECO:0007829|PDB:6YIO"
FT   STRAND          174..177
FT                   /evidence="ECO:0007829|PDB:6YIO"
FT   STRAND          182..185
FT                   /evidence="ECO:0007829|PDB:2B5I"
SQ   SEQUENCE   272 AA;  30819 MW;  83D907C8C81D2C0E CRC64;
     MDSYLLMWGL LTFIMVPGCQ AELCDDDPPE IPHATFKAMA YKEGTMLNCE CKRGFRRIKS
     GSLYMLCTGN SSHSSWDNQC QCTSSATRNT TKQVTPQPEE QKERKTTEMQ SPMQPVDQAS
     LPGHCREPPP WENEATERIY HFVVGQMVYY QCVQGYRALH RGPAESVCKM THGKTRWTQP
     QLICTGEMET SQFPGEEKPQ ASPEGRPESE TSCLVTTTDF QIQTEMAATM ETSIFTTEYQ
     VAVAGCVFLL ISVLLLSGLT WQRRQRKSRR TI
//
